AbbVie Inc. (ABBV:NYSE)

Last update - 1 November 2022 By Rivkin

AbbVie Inc. (ABBV) posted a revenue of $14.81 billion, 3.2% higher than last year with an EPS of $3.66.

We are glad you are enjoying our content and we’d like to help you achieving your financial goals.

This content is only for Rivkin Report Members.

Start a free 14-day trial to access this article and:

  • 6 Model Portfolios for Income and Growth

  • In-Depth Stock Analysis: identify potential investment opportunities

  • Q&A sessions with our CIO, Shannon Rivkin

Be the first to know. Get the Morning Market Wrap each morning.